XML 88 R74.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation Expense and Shareholders' Equity (Details 3) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2023
Number of RSUs Outstanding (in shares)      
Balance at beginning of period (in shares) 3,202,066    
Balance at end of period (in shares) 2,672,857 3,202,066  
Weighted Average Grant Date Fair Value (in dollars per share)      
Granted (in USD per share) $ 63.29    
Aggregate Intrinsic Value      
Balance at beginning of period $ 480,534 $ 289,635 $ 216,478
Released 284,544 168,144 97,324
Balance at end of period 604,654 $ 480,534 $ 289,635
Expected to vest, Aggregate Intrinsic Value $ 604,654    
Share price (in dollars per share) $ 226.22 $ 150.07 $ 84.82
Stock awards      
Number of RSUs Outstanding (in shares)      
Balance at beginning of period (in shares) 3,202,066 3,414,706 2,785,353
Granted (in shares) 1,099,795 1,639,400 2,287,778
Released (in shares) (1,473,839) (1,569,451) (1,391,162)
Canceled (in shares) (155,165) (282,589) (267,263)
Balance at end of period (in shares) 2,672,857 3,202,066 3,414,706
Expected to vest (in shares) 2,672,857    
Weighted Average Grant Date Fair Value (in dollars per share)      
Balance at beginning of period (in USD per share) $ 86.60 $ 85.68 $ 110.47
Granted (in USD per share) 179.92 93.63 66.36
Released (in USD per share) 99.72 91.48 100.92
Canceled (in USD per share) 95.42 89.22 99.31
Balance at end of period (in USD per share) 117.25 $ 86.60 $ 85.68
Expected to vest (in USD per share) $ 117.25